43 related articles for article (PubMed ID: 33657249)
1. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition.
Mitchell E; Jindal S; Chan T; Narasimhan J; Sivagnanam S; Gray E; Chang YH; Weinmann S; Schedin P
Mol Carcinog; 2020 Jul; 59(7):701-712. PubMed ID: 32134153
[TBL] [Abstract][Full Text] [Related]
2. Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?
Zhang X; Hashemi SS; Yousefi M; Ni J; Wang Q; Gao L; Gong P; Gao C; Sheng J; Mason J; Man YG
Int J Biol Sci; 2008 Aug; 4(5):259-69. PubMed ID: 18726004
[TBL] [Abstract][Full Text] [Related]
3. TGFβ-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression.
Gibson SV; Tomas Bort E; Rodríguez-Fernández L; Allen MD; Gomm JJ; Goulding I; Auf dem Keller U; Agnoletto A; Brisken C; Peck B; Cameron AJ; Marshall JF; Jones JL; Carter EP; Grose RP
NPJ Breast Cancer; 2023 Mar; 9(1):9. PubMed ID: 36864079
[TBL] [Abstract][Full Text] [Related]
4. Defining invasion in breast cancer: the role of basement membrane.
Ghannam SF; Rutland CS; Allegrucci C; Mongan NP; Rakha E
J Clin Pathol; 2023 Jan; 76(1):11-18. PubMed ID: 36253088
[TBL] [Abstract][Full Text] [Related]
5. What if COVID-19 affects the child: which weapons and how to use them.
Anedda L; Bianchini L; Cuzzolin L; Finco G; Fanos V; Marcialis MA
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3325-3337. PubMed ID: 33928620
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract][Full Text] [Related]
7. The most likely but largely ignored triggering factor for breast (or all) cancer invasion.
Man YG; Mannion C; Stojadinovic A; Peoples GE; Cho WC; Fu SW; Tan X; Hsiao YH; Liu A; Semczuk A; Zarogoulidis P; Gapeev AB; Deng X; Peng X; Reva BA; Omelchenko T; Wang J; Song G; Chen T
J Cancer; 2023; 14(4):573-590. PubMed ID: 37057291
[TBL] [Abstract][Full Text] [Related]
8. ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.
Werner M; Dyas A; Parfentev I; Schmidt GE; Mieczkowska IK; Müller-Kirschbaum LC; Müller C; Kalkhof S; Reinhardt O; Urlaub H; Alves F; Gallwas J; Prokakis E; Wegwitz F
Cell Death Dis; 2022 Sep; 13(9):762. PubMed ID: 36057630
[TBL] [Abstract][Full Text] [Related]
9. Identifying progression predictors of breast ductal carcinoma in situ.
Yeong J; Thike AA; Tan PH; Iqbal J
J Clin Pathol; 2017 Feb; 70(2):102-108. PubMed ID: 27864452
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.
Barsky SH; Karlin NJ
Nat Clin Pract Oncol; 2006 Mar; 3(3):138-51. PubMed ID: 16520804
[TBL] [Abstract][Full Text] [Related]
11. Neural EGFL like 2 expressed in myoepithelial cells and suppressed breast cancer cell migration.
Nakamura R; Oyama T; Inokuchi M; Ishikawa S; Hirata M; Kawashima H; Ikeda H; Dobashi Y; Ooi A
Pathol Int; 2021 May; 71(5):326-336. PubMed ID: 33657249
[TBL] [Abstract][Full Text] [Related]
12. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
13. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
14. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
